Skip to main content
. 2021 Aug 6;11:686044. doi: 10.3389/fonc.2021.686044

Table 1.

Clinical characteristics of BLCA patients in the TCGA cohort and GEO GSE13507.

Characteristics TCGA Total (n = 372) GEO Total (n = 165)
Age (years) <60 79 (21.2%) 42 (25.5%)
≥60 293 (78.7%) 123 (74.5%)
Gender Male 276 (74.2%) 135 (81.8%)
Female 96 (25.8%) 30 (18.2%)
T stage 1 T0 1 (0.3%) 0
T1 4 (1.1%) 80 (48.5%)
T2 116 (31.2%) 31 (18.8%)
T3 193 (51.9%) 19 (11.5%)
T4 57 (15.3%) 11 (6.7%)
Tx 1 (0.3%) 24 (14.5%)
T stage 2 T0–2 121 (32.5%) 111 (67.3%)
T3–4 251 (67.5%) 30 (18.2%)
Tx 1 (0.3%) 24 (14.5%)
Lymph node metastasis Yes 124 (33.3%) 15 (9.1%)
No 221 (59.4%) 149 (90.3%)
Unknown 27 (7.3%) 1 (0.61%)
Metastasis Yes 8 (2.2%) 7 (4.2%)
No 183 (49.2%) 158 (95.8%)
Unknown 181 (48.7%) 0
Diagnosis subtype Papillary 117 (31.5%) NA
Non-papillary 250 (67.2%) NA
Unknown 5 (1.3%) NA
Histologic grade High 351 (94.4) 60 (36.4%)
Low 19 (5.1%) 105 (63.6%)
Unknown 2 (0.5%) 0
Vital status Dead 166 (44.6%) 69 (41.8%)
Alive 206 (55.4%) 96 (58.2%)

NA, Not Applicable.